Opioid Use Disorder Outcomes In another study by Wang, Volkow, and colleagues, which included roughly 33,000 individuals with Type 2 diabetes and opioid use disorder, semaglutide was associated with a 42-68% lower risk of opioid overdoses compared to other diabetes medications during the 1-year follow-up period (Wang et al., 2024b)
Blood sugar spikes: GLP-1s help regulate glucose levels, so discontinuing the drug can cause blood sugar to rise, especially in people with Type 2 diabetes
2008;67(Suppl 3):iii49-iii55
Common Side Effects Participants in clinical studies reported: Nausea Vomiting Diarrhea Reduced appetite These symptoms typically occur during the dose escalation phase and often decrease over time
Monitoring them ensures your metabolism is primed for weight loss
Archived from the original on 25 December 2019